No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia.
- 1 August 1996
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 98 (3), 793-799
- https://doi.org/10.1172/jci118852
Abstract
Pain treatment with centrally acting opiates is limited by tolerance. Tolerance is a decreasing effect of a drug with prolonged administration of that drug or of a related (e.g., endogenous) compound acting at the same receptor. This is often associated with a downregulation of receptors. In peripheral inflamed tissue, both locally expressed opioid peptides and morphine can produce powerful analgesia mediated by similar populations of opioid receptors. We hypothesized that the chronic presence of endogenous opioids in inflamed joints might convey downregulation of peripheral opioid receptors and tolerance to the analgesic effects of intraarticular morphine. We assessed these effects after arthroscopic surgery in patients with and without histologically verified synovial cellular infiltration, and we examined synovial opioid peptides and opioid receptors by immunocytochemistry and autoradiography, respectively. We found that, despite an abundance of opioid-containing cells in pronounced synovitis, morphine is at least as effective as in patients without such cellular infiltrations, and there is no major downregulation of peripheral opioid receptors. Thus, opioids expressed in inflamed tissue do not produce tolerance to peripheral morphine analgesia. Tolerance may be less pronounced for peripherally than for centrally acting opioids, which provides a promising perspective for the treatment of chronic pain in arthritis and other inflammatory conditions.This publication has 31 references indexed in Scilit:
- Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.Proceedings of the National Academy of Sciences, 1994
- Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.1993
- Control of receptor sensitivity at the mRNA levelMolecular Neurobiology, 1993
- Local analgesic effect of endogenous opioid peptidesThe Lancet, 1993
- Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissueNeuroscience, 1993
- Peripheral Mechanisms of Opioid AnalgesiaAnesthesia & Analgesia, 1993
- Opioid agonists and antagonists: An evaluation of their peripheral actions in inflammationMedicinal Research Reviews, 1992
- Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociceptionNeuroscience, 1992
- Analgesic Effect of Intraarticular Morphine after Arthroscopic Knee SurgeryNew England Journal of Medicine, 1991
- Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.Proceedings of the National Academy of Sciences, 1990